Agonist or antagonist: what is preferable for in vitro fertilization??

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.28, Iss.1, 2012-03, pp. : 18-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization

By Mohamed Kamel Abdelhakim Davies William Lashen Hany

Gynecological Endocrinology, Vol. 22, Iss. 2, 2006-02 ,pp. : 57-62

Informa Healthcare

Access to resources Recommend Favorite

Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?

By Lin Y

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 885-888

Oxford University Press

Access to resources Recommend Favorite

Relationship between gonadotropin releasing hormone agonist dosage and in vitro fertilization outcome

By Lorusso F. Depalo R. Selvaggi L.

Gynecological Endocrinology, Vol. 18, Iss. 2, 2004-01 ,pp. : 69-73

Informa Healthcare

Access to resources Recommend Favorite

Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer

By Depalo Raffaella Lorusso Filomenamila Palmisano Marcella Bassi Emma Totaro Ilaria Vacca Margherita Trerotoli Paolo Masciandaro Paola Selvaggi Luigi

Gynecological Endocrinology, Vol. 25, Iss. 5, 2009-05 ,pp. : 328-334

Informa Healthcare

Access to resources Recommend Favorite

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

By Elgendy M Afnan M

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2382-2385

Oxford University Press

Access to resources Recommend Favorite